Andera Partners, Unigrains and BPI France have invested in French business Tournus Group, alongside the company's management, which increased its majority holding.
New and historical backers invest in Belgium-based Imcyse, a developer of immunotherapies
Ergon uses its Ergon Capital Partners IV vehicle, which closed on €580m in March 2019
Buyout of the baking product company is the GP's fifth UK deal since opening a Manchester office
Sale ends an eight-year holding period for the GP, which owned an 83.4% stake in the company